Rare Disease Drug Approvals Accelerate as FDA Clears Three New Orphan Therapies
May 2026 — The U.S. Food and Drug Administration has approved three therapies in May…
𝗙𝗿𝗼𝗺 𝗦𝗺𝗮𝗹𝗹 𝗣𝗼𝗽𝘂𝗹𝗮𝘁𝗶𝗼𝗻𝘀 𝘁𝗼 𝗦𝗺𝗮𝗿𝘁𝗲𝗿 𝗧𝗿𝗶𝗮𝗹𝘀
𝗧𝗵𝗲 𝗘𝘃𝗼𝗹𝘃𝗶𝗻𝗴 𝗥𝗮𝗿𝗲 𝗢𝗻𝗰𝗼𝗹𝗼𝗴𝘆 𝗟𝗮𝗻𝗱𝘀𝗰𝗮𝗽𝗲 Rare and orphan oncology is experiencing a transformation driven by…
End of content
End of content